baber/WOPTO huggingface dataset:
Patent IL-93621-A0 (IL)
Title: Method and apparatus for determining non-triglycerides in oils
IPC: G01N31/00
Filed: 1990-03-02
Abstract: A method and diagnostic test unit for the determination of one or more non-triglycerides in an oil using an oil-miscible test solution prepared from an oil-miscible vehicle of monoglycerides, diglycerides or mixtures thereof and an indicator deliverable in admixture with the vehicle for assaying the non-triglycerides, wherein the indicator in combination with the non-triglycerides forms a reaction product characteristic of the amount of the non-triglycerides, and the indicator and vehicle are present in quantities and at a pH effective to provide detectable quantities of reaction product. The reaction product development is compared to a known standard to determine the presence or amount of the non-triglycerides in the oil.
Patent IL-95766-A0 (IL)
Title: Recombinant dna expression vectors and dna compounds that encode acyltransferase activity of aspergillus
IPC: C12N1/21
Filed: 1990-09-24
Abstract: The present invention provides DNA compounds that encode isopenicillin N:acylCoA acyltransferase activity of Aspergillus nidulans. The compounds can be used to construct recombinant DNA expression vectors for a wide variety of host cells, including E. coli, Penicillium, and Aspergillus. The invention also provides methods for producing cephalosporins in penicillin N-producing fungi.
Patent FI-20000956-A0 (FI)
Inventor: RASI SIMO
IPC: A61K8/00
Filed: 2000-04-20
Abstract: The present invention relates to a cream composition containing BT-vitamin i.e. carnitine and/or B13-vitamin i.e. orotic acid. The invention also describes a method of preparing the above mentioned compositions, which may preferably be injected into a gel whereby small chaplet-like balls preferably of different colors are formed which may be used for dermatological purposes.
Patent FI-20010760-A0 (FI)
Inventor: TAEHTINEN ILKKA
IPC: H04H40/18
Filed: 2001-04-11
Abstract: The invention relates generally to a method and an arrangement for receiving a radio frequency (RF) signal and an RF receiver. Particularly the invention relates to controlling and reducing power consumption in a radio receiver. The invention can advantageously be applied in receiving arrangements of radio systems, wherein information is transferred in bursts, such as a receiver of Digital Video Broadcasting (DVB) system. According to the invention, during the time between two bursts the power supply is maintained in at least in some parts of the phase locked loop PLL (240), while one or several other parts (202, 204, 224, 225, 230, 262, 270) of the receiver are turned off for a certain time period between the two bursts. The present invention enables fast tuner lock-in time and still offers a considerable saving in total power consumption of the receiver. <IMAGE>
Patent FI-20021545-A0 (FI)
Inventor: JAERVINEN TOMI
IPC: A23L33/105
Filed: 2002-08-29
Abstract: An inclusion complex of a lignan or lignan ester with a cyclodextrin. Also disclosed are food products, dietary supplements and pharmaceutical compositions containing the complex.
Patent IL-100943-A0 (IL)
Title: Reduced polydextrose
IPC: A23L27/30
Filed: 1992-02-13
Abstract: A polydextrose having improved color, flavor and decreased reactivity toward food ingredients having amine functionality. The polydextrose comprises a water-soluble highly branched polydextrose having been prepared by a process which comprises melting dextrose in the presence of a food-acceptable acid catalyst. The improved polydextrose of this invention has substantially no reducing glucose groups. Another aspect of this invention is directed to a method of making the above-described improved polydextrose which comprises exposing unimproved polydextrose to an environment capable of chemically transforming the reducing glucose groups contained in the unimproved polydextrose, thereby substantially eliminating their reducing properties. An improved polymaltose prepared by heating maltose in the presence of a food-acceptable acid catalyst and chemically transforming the reducing glucose groups contained in the polymaltose, thereby eliminating their reducing properties, is also described.
Patent IL-102430-A0 (IL)
Title: Connection element for jewellery
IPC: A44C5/20
Filed: 1992-07-06
Abstract: PCT No. PCT/EP92/01495 Sec. 371 Date Mar. 10, 1993 Sec. 102(e) Date Mar. 10, 1993 PCT Filed Jul. 3, 1992 PCT Pub. No. WO93/02584 PCT Pub. Date Feb. 18, 1993.The connection element (2, 3) according to the present invention comprises a housing, and is capable of forming a symmetrical body such as a sphere (1) in cooperation with a second, essentially identical connection element as a result of the assembly of said two elements in mutually upside-down orientation. The interface portions between the housings of the two elements (2, 3) comprise portions which are cut in a plane parallel to the axis of the sphere, which axis is defined as the line which passes through the two opposing fixation points of the sphere to the ends of a necklace or the like, as well as portions which are cut in a plane which is inclined with respect to this axis to permit maintenance of the engagement of the two connection elements even under the application of a traction force onto the two fixation points. The elements according to the present invention comprise also two flexible pins (6, 7) which permit to maintain two connection elements in their respective engaged positions.
Patent IL-114785-A0 (IL)
Title: Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
IPC: C07D209/00
Filed: 1995-07-31
Abstract: Compounds represented by the Formula I: <CHEM>  wherein:     R<1> is hydrogen or lower alkyl;     R<2> is heteroaryl; and     R<3> and R<4> are independently hydrogen or lower alkyl; and the pharmaceutically acceptable salts thereof, are useful as chemotherapeutic agents.
Patent IL-115951-A0 (IL)
Title: Improved method for preparing opipramol
IPC: C07D223/26
Filed: 1995-11-09
Abstract: An improved method for preparing opipramol (I) is disclosed, wherein iminostilbene (II) is reacted with 1-bromo-3-chloropropane in the presence of a weak base selected from a hydrogen phosphate salt and an acetate salt and in the presence of a phase transfer agent to produce N-(3-halopropyl)iminostilbene (III), which is mixture of N-(3-chloropropyl)iminostilbene and N-(3-bromopropyl)iminostilbene, and then N-(3-halopropyl)iminostilbene is reacted with N-(2-hydroxyethyl)piperazine to form opipramol, as shown in the following equations, where X is chlorine or bromine.   <IMAGE>    <IMAGE>  +TR
Patent IL-125628-A0 (IL)
Title: Benzo[c] quinolizine derivatives their preparation and use as 5alpha-reductase inhibitors
IPC: C07D455/03
Filed: 1997-02-07
Abstract: The present invention refers to benzo[c]quinolizine derivatives of general formula (I)their pharmaceutically acceptable salts or esters, processes for their preparation and pharmaceutical compositions containing them.
Patent IL-181271-A0 (IL)
Title: Triazolophthalazine derivatives and pharmaceutical compositions containing the same
Filed: 2007-02-11
Abstract: The compounds of formula I in which R1 and R2 have the meanings as given in the description are novel effective PDE2 inhibitors.
Patent IL-195656-A0 (IL)
Title: Borane ether complexes
Filed: 2008-12-02
Abstract: The present invention relates to a borane ether complex of the formula 1, wherein R1 to R4 represent independently from each other hydrogen, C1-C4-alkyl, C3-C6-cycloalkyl or a substituent of the formula CH2OR5, wherein R5 is C1-C4-alkyl or C3-C6-cycloalkyl, or two adjacent substituents R1 to R4 together are a divalent group selected from the group consisting of -CH2CH2-, -CH(CH3)CH2-, -CH2CH2CH2-, -CH(CH3)CH(CH3)-, -CH(CH2CH3)CH2-, -C(CH3)2C(CH3)2-, -CH2C(CH3)2CH2- and -(CH2)6- to form with the -CH-CH- moiety of the tetrahydrofuran ring a cyclic structure, with the provision that at least one of the substituents R1 to R4 is not hydrogen. The invention also relates to a method of using new borane complexes with substituted tetrahydrofuran ethers for organic reactions.
Patent IL-205567-A0 (IL)
Title: Method and apparatus for performing mobile assisted hard handoff between communication systems
IPC: H04W36/14
Filed: 2010-05-05
Abstract: A method and apparatus for performing inter-system hard handoff between communication systems or inter-frequency hard handoff within a CDMA communication system is disclosed. The purpose of this invention is to reduce the probability of dropped calls during inter-system hard handoff. In the event that a hard handoff attempt is unsuccessful, the mobile station will return to the original system with information which the communication system of the present invention uses to assist in the performance of future handoff attempts. Alternatively, with no handoff attempt made, the mobile station monitors the destination system then returns to the original system with information used to assist in subsequent handoff attempts. The information returned from monitoring a CDMA system consists of results of a search for one or more pilots given at offsets in a specific list provided to the mobile station by the base station or a set of offsets based upon a predetermined search algorithm.
Patent MA-20038-A1 (MA)
Inventor: FRANK E MATYJA
IPC: B29D30/30
Filed: 1984-02-20
Abstract: A method of making radial pneumatic tires substantially reduces or eliminates sidewall indentations in the inflated tire. A plurality of cuts is made in one end of each layer of ply fabric where the end of the ply fabric overlaps the other end to form a splice which results in the generally annular shape of the ply layer. The cuts extend in a direction generally transverse to the end edge and preferably have a length which is approximately the same as the width of the overlap of the cut edge with the other edge. The cuts prevent overtensioning of the ply cords, which otherwise result in sidewall indentations.
Patent MA-22107-A1 (MA)
Inventor: T HATSUDA
IPC: C08J3/00
Filed: 1991-04-01
Abstract: A method for treating the surface of an absorbent resin which comprises mixing (I) 100 parts by weight of an absorbent resin powder having a carboxyl group, (II) 0.01 to 30 parts by weight of a polyhydric alcohol, (III) 0 to 50 parts by weight of water and (IV) 0 to 60 parts by weight of a hydrophilic organic solvent, and heat-treating at a temperature in the range of 90 to 250 DEG C to treat the surface of said absorbent resin powder (I) until the reaction of said absorbent resin powder (I) with said polyhydric alcohol (II) is completed, wherein the time for completion of the reaction is the time that satisfies the following equation (a-1): <MATH> wherein A is absorption capacity of said absorbent resin powder (I) for physiological saline solution, B is the absorption capacity of the resultant treated absorbent resin for physiological saline solution, and C is parts by weight of said polyhydric alcohol (II) used per 100 parts by weight of said absorbent resin powder (I).
Patent MA-23031-A1 (MA)
Inventor: GUILIO CAMBIUZZI
IPC: E04B1/00
Filed: 1993-11-16
Abstract: PCT No. PCT/EP93/03203 Sec. 371 Date Jul. 18, 1995 Sec. 102(e) Date Jul. 18, 1995 PCT Filed Nov. 15, 1993 PCT Pub. No. WO94/11587 PCT Pub. Date May 26, 1994A building block comprises a transverse groove (12) in each end face (10b, 10c), an opening (15) extending from the first (10e) to the second bearing face (10d) in which a longitudinal groove (13, 14) is also provided. The block is further provided with reference and positioning structure comprising a pair of longitudinal seats on the first bearing face and a pair of projections, each divided into three projection portions, on the second bearing face. When a building structure is constructed, the blocks 10 are superposed dry and in a staggered arrangement in superposed rows, such that the longitudinal seats of each block engage the projections on the blocks of the underlying row. The apertures and the grooves in the blocks constituting the building structure form a grid of intersecting vertical and horizontal channels which extend over the entire building structure, and in which a binder is poured and solidifies, ensuring that the building structure is stable and resistant over time.
Patent MA-24762-A1 (MA)
Inventor: VEN LIVIEN DOMIEN
IPC: F24J2/54
Filed: 1999-02-16
Abstract: Device for heating with solar energy, which device contains at least one mirror construction (1) which is mounted on a frame (3) in a movable manner and which be directed towards the sun, and at least one collector (4) extending parallel to the mirror construction (1) in order to collect the solar radiation reflected by the mirror construction (1), characterized in that the mirror construction (1) contains a number of almost flat mirror strips (2) extending next to one another in the longitudinal direction of the collector (4) and which are each provided on the frame (3) such that they can rotate around their longitudinal direction, whereas the collector (4) is stationary in relation to the frame (3), whereby the mirror strips (2) are situated in an almost horizontal plane with their axes of rotation, whereby the device contains means (16) to rotate the mirror strips (2) and the mirroring surface of the mirror strips (2) such that the solar rays coming in on said surface can be reflected towards the collector (4).
Patent MA-37472-A1 (MA)
Title: Composés hétérocycliques et leurs utilisations
Inventor: BUI MINNA HUE THANH
IPC: C07D401/14
Filed: 2013-04-04
Abstract: L'invention concerne des hétéroaryles bicycliques substitués et des compositions les contenant, pour le traitement d'une inflammation générale, de l'arthrite, de maladies rhumatismales, de l'arthrose, de troubles inflammatoires intestinaux, de troubles oculaires inflammatoires, de troubles inflammatoires ou de vessie instable, du psoriasis, d'affections cutanées avec composantes inflammatoires, d'états inflammatoires chroniques, y compris mais de façon non limitative, les maladies auto-immunes telles que le lupus érythémateux disséminé (led), la myasthénie grave, l'arthrite rhumatoïde, l'encéphalomyélite aiguë disséminée, le purpura thrombocytopénique idiopathique, la sclérose en plaques, le syndrome de sjögren et l'anémie hémolytique auto-immune, les états allergiques comprenant toutes formes d'hypersensibilité. La présente invention concerne également des méthodes de traitement de cancers qui sont médiés par, dépendants de ou associés à l'activité p110, y compris mais de façon non limitative, des leucémies, telles que la leucémie myéloïde aiguë (lma), le syndrome myélodysplasique (smd), les maladies myélo-prolifératives (smp), la leucémie myéloïde chronique (lmc), la leucémie lymphoblastique aiguë à cellules t (lla-t), la leucémie lymphoblastique aiguë à cellules b (lla-b), le lymphome non hodgkinien (lnh), le lymphome à cellules b et les tumeurs solides, telles que le cancer du sein.
Patent MA-38874-A1 (MA)
Title: Forme de filet à 4 tours
Inventor: MOORE LAWRENCE
IPC: F16L15/06
Filed: 2014-07-31
Abstract: L'invention concerne un appareil qui forme une forme de filet de tuyauterie à quatre filets par diamètre-tuyaux en pouces (tpi). La forme de filet est conçue de manière à présenter un flanc de charge, un angle de flanc de charge, un flanc de guidage, un angle de flanc de guidage, un sommet et une base. Des essais par pression hydrostatique au moyen de la forme de filet à 4 tours à des pressions égales et supérieures à 4500 psi ont provoqué des pannes en raison de fuites de filet. Des essais de traction au moyen de la forme de filet à 4 tours à des charges égales et supérieures à 187400 lbs ont provoqué un cisaillement à des forces égales et supérieures à 3535 psi.
Patent MA-51931-A1 (MA)
Title: Garniture pour volet d'airbag
Inventor: EMERY PASCAL
IPC: B60R21/20
Filed: 2019-05-07
Abstract: La présente invention a pour objet une garniture (1) comprenant au moins une ligne d'affaiblissement (2) et destinée à être positionnée sur un volet d'airbag, caractérisée en ce que la ligne (2) comporte un profil (4) d'évidement discontinu dans l'épaisseur de la garniture (1) dont la section dans un plan perpendiculaire au plan de la garniture (1) et au plan de la ligne d'affaiblissement (2) présente la forme d'une ogive.
Patent UY-23640-A1 (UY)
Title: Procedimiento de elaboracion de fosfato de levamisol inyectable
IPC: A61P33/10
Filed: 1993-08-31
Abstract: Procedimiento de eleboración de fosfato de levamisol inyectable, caracterizado por disponer en un recipiente sanitario agua para inyectables, agregándose ácido fosfórico, tal que esa mezcla se enfría y se le agrega entonces y lentamente, levamisol base hasta lograr una dilución total, resultando un medio con pH 2 o menor. Con el medio estabilizado, se le agrega lentamente, en forma sucesiva y comprobando la dilución total de cada producto, antes de agregar el siguiente, los componentes: propilenglicol, citrato de sodio, ácido cítrico, EDTA disódico, nipagin, nipasol y metabisulfito de sodio. Posteriormente se estabiliza el producto por filtración y se envasa.
Patent UY-25544-A1 (UY)
Title: Forma de dosificación de nefazodona
Inventor: HODSDON AMDREW B DENNIS PETER
IPC: A61K31/495
Filed: 1999-06-04
Abstract: Las composiciones de nefazodona de liberación prolongada, que contienen clorhidrato de nefazodona, polímeros de gelificación iónico y no iónico, un agente hidrofílico insoluble, y excipientes opcionales farmacéuticamente aceptables, demuestran liberación de la nefazodona, modulada por el pH. Estas composiciones son formuladas en formas de dosis unitaria para la administración oral mejorada. Los mejoramientos comprenden un perfil prolongado de liberación edl fármaco, proporcionando niveles comparativos de nefazodona con respecto a las formas de dosificación de liberación inmediata y además, que demuestran la falta de un efecto por alimento.
Patent UY-26926-A1 (UY)
Title: Derivados de la quinolina y quinazolina
Inventor: DAUTZENBERG F
IPC: A61P43/00
Filed: 2001-09-05
Abstract: Los compuestos de fórmula I así como las sales utilizables farmacéuticamente, solvatos y ésteres del mismo en donde R1, R2, R3, R4, A1 y A2 tienen el significado dado en la reivindicación 1, se pueden usar en forma de preparaciones farmacéuticas para el tratamiento o prevención de artritis, enfermedades cardiovasculares, diabetes, insuficiencia renal, trastornos alimentarios y obesidad.
Patent UY-28092-A1 (UY)
Title: Composiciones que imitan al queso para empleo en la manufactura de barras de queso, rebanadas y similares y metodo de produccion de dichas composiciones
Inventor: JACOBSON MICHAEL R
Filed: 2003-11-24
Abstract: Composición que imita al queso que contiene humedad, preferentemente en una cantidad de por lo menos un 60% del peso, un hidrocoloide, un componente derivado del queso en una cantidad inferior a cerca del 15% del peso de la composición, saborizante de queso ya sea natural o artificial y acidificante en una cantidad tal que logre que el pH de la composición no sobrepase 4,6. La composición es lo suficientemente firme como para que se pueda efectuar por lo monos uno de los procesos siguientes: rebanar, cortar, picar o rallar. Preferentemente, contiene no más de un 1% de proteína y/o el acidificante está presente en una cantidad titulable inferior a un 1.5% del peso de la composición, resultando en una composición que imita al queso que tiene un sabor, textura y consistencia que solamente se podía obtener anteriormente en productos de queso preparados mediante el proceso de pasteurización.
Patent UY-28721-A1 (UY)
Title: Derivados de sulfonamida para eltratamiento de enfermedades
Inventor: GLOSSOP PAUL ALAN
IPC: C07D217/06
Filed: 2005-01-19
Abstract: La invención se refiere a compuestos de fórmula (1) y a procedimientos para la preparación de, a intermedios usados en la preparación de, a composiciones que contienen y a los usos de tales derivados. Los compuestos de acuerdo con la presente invención son útiles en numerosas enfermedades, trastornos y afecciones, en particular enfermedades, tratornos y afecciones inflamatorias, alérgicas y respiratorias.
Patent UY-28732-A1 (UY)
Title: Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico, procesos para su preparación y su uso como medicamentos.
Inventor: DEFOSSA DR ELISABETH
IPC: C07F9/60
Filed: 2005-01-31
Abstract: La invención se refiere a derivados de ácido 7-fenilamino-4-quinolona-3-carboxílico y a lsa sales fisiológicamenten toleradas y derivadaos fisiológicamente funcionales de los mismos. Esta invención se refiere a compuestos de la fórmula I en la que los radicales tienen los significados indicados, y a las sales fisiológicamente toleradas de los mismos.Los compuestos son adecuados, por ejemplo, como medicamentos para la prevención y tratamiento de la diabetes de tipo 2.
Patent UY-28785-A1 (UY)
Title: Derivados de 4-benzimidazol-2-il-piridazin-3-ona, preparación de los mismos y su empleo en medicamentos
Inventor: MATTER DR HANS
Filed: 2005-03-02
Abstract: La invención se refiere acompuestos según la fórmula general (I), estando expuestas las definiciones de los sustituyentes A, B, D, E, R1 y R2 en la memoria descriptiva, y a sus sales fisiológicamente tolerables, aprocedimientos para la preparación de estos compuestos, y a su empleo como medicamentos. Estos compuestos son inhibidores de cinasas, en especial inhibidores de la cinasa GSK-3(beta) (glicogenosintasacinasa-3B(beta)).
Patent UY-30590-A1 (UY)
Title: Composicion y método para el procesamiento del papel
Inventor: LEWIS CHRISTOPHER MICHAEL
IPC: D21D1/00
Filed: 2007-09-14
Abstract: De acuerdo con la presente invencion, se provee un proceso para fabricar papel o carton que comprende formar una suspension celulosica que puede comprende o no un relleno, flocular la suspension celulosica, drenar la suspension celulosica en un tamiz para formar una hoja, en donde la suspension celulosica es floculada mediante un sistema de floculacion que comprende la adicion secuencial o simultánea de un material silíceo y un micropolímero orgánico, cationico o anionico, de agua-en-agua o de dispersion en una solucion salina.
Patent UY-31418-A1 (UY)
Title: Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos
Inventor: ROURA VICTOR GRIFOLS
IPC: A61P25/00
Filed: 2008-10-23
Abstract: La invencion se basa en la utilizacion de albumina humana terapéutica para la preparacion de un medicamento par el tratamiento de pacientes afectados por desordenes cognitivos, en la que el modelo de administracion del medicamento comprende la administracion al paciente de un mínimo de tres veces sucesivas, de una cantidad terapéuticamente efectiva de albumina terapéutica humana mediante recambio plasmático y/o perfusion intravenosa, sin dependencia del contenido de AB(Beta) en sangre del paciente.
Patent AT-501201-A1 (AT)
Title: Air-cooled internal combustion engine has cylinder, ventilator housing which partially surrounds cylinder housing whereby means is provided for deviating semi-axial flow of cooling flow emerging from blower wheel
Inventor: LAIMBOECK FRANZ DR
Filed: 2005-01-13
Abstract: An air-cooled internal combustion engine has one cylinder (2), a ventilator housing (6) which partially surrounds the cylinder housing (12), wherein one blower wheel (7) which is driven, by a crankshaft (5), is arranged. Means is provided for deviating the semi-axial flow of the cooling flow (10) emerging from the blower wheel. An independent claim is also included for four stroke internal combustion engine with two intake valves.